| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4169613 | The Journal of Pediatrics | 2006 | 8 Pages |
Abstract
Rituximab may be an effective co-therapy; however, further investigations are required because severe adverse events occurred in 45% of the patients in this study.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
M. MD, E. MD, PhD, P. MD, I. MD, A. MD, P. MD, PhD, G. MD, PhD, F. MD, T. MD, B. MD, C. MD, P. MD, B. MD, R. MD, PhD, T. MD, Brigitte MD, French pediatric-onset SLE study group French pediatric-onset SLE study group,